AIM
AIM
AMEX · Biotechnology

Aim Immunotech Inc

$0.21
0.00 (-0.86%)
As of Sep 22, 6:00 PM ET ·
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Buy 5 83%
Hold 1 17%
Sell 0 0%
Price Target
Analyst Price Target +10,540.3% upside
Low Target $15.13
Average Target $22.10
High Target $31.02
Current Price $0.21
Current
$0.21
Target
$22.10
$15.13 $22.10 avg $31.02
Scenario Analysis
Bear Case
$15.13
7,184.5%
Low target
Base Case
$22.10
+10,540.3%
Avg target
Bull Case
$31.02
+14,835.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.89
-92.8% from high
52-Week Low
$0.19
+9.3% from low
Target vs 52W High
$22.10
+664.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%